The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry

Castleman disease (CD) describes a group of rare, potentially fatal lymphoproliferative disorders. To determine factors associated with mortality in CD, we analysed data from deceased patients in the ACCELERATE registry and compared them with matched controls. We analysed demographic, treatment and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajgenbaum, David C., Pierson, Sheila K., Kanhai, Karan, Bagg, Adam, Alapat, Daisy, Lim, Megan S., Lechowicz, Mary Jo, Srkalovic, Gordan, Uldrick, Thomas S., van Rhee, Frits
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematological Malignancy‐clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544190/
https://www.ncbi.nlm.nih.gov/pubmed/35507638
http://dx.doi.org/10.1111/bjh.18214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544190/
https://www.ncbi.nlm.nih.gov/pubmed/35507638
http://dx.doi.org/10.1111/bjh.18214

Ejemplares similares